Treatment of localised renal cell carcinoma

Hein Van Poppel, Frank Becker, Jeffrey A. Cadeddu, Inderbir S. Gill, Gunther Janetschek, Michael A S Jewett, M. Pilar Laguna, Michael Marberger, Francesco Montorsi, Thomas J. Polascik, Osamu Ukimura, Gang Zhu

Research output: Contribution to journalArticle


Context: The increasing incidence of localised renal cell carcinoma (RCC) over the last 3 decades and controversy over mortality rates have prompted reassessment of current treatment. Objective: To critically review the recent data on the management of localised RCC to arrive at a general consensus. Evidence acquisition: A Medline search was performed from January 1, 2004, to May 3, 2011, using renal cell carcinoma, nephrectomy (Medical Subject Heading [MeSH] major topic), surgical procedures, minimally invasive (MeSH major topic), nephron-sparing surgery, cryoablation, radiofrequency ablation, surveillance, and watchful waiting. Evidence synthesis: Initial active surveillance (AS) should be a first treatment option for small renal masses (SRMs)

Original languageEnglish
Pages (from-to)662-672
Number of pages11
JournalEuropean Urology
Issue number4
Publication statusPublished - Oct 2011


  • Active surveillance
  • Cryotherapy
  • Nephron-sparing surgery
  • Partial nephrectomy
  • Radical nephrectomy
  • Radiofrequency ablation
  • Renal cell carcinoma
  • Small renal mass

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Treatment of localised renal cell carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Van Poppel, H., Becker, F., Cadeddu, J. A., Gill, I. S., Janetschek, G., Jewett, M. A. S., Laguna, M. P., Marberger, M., Montorsi, F., Polascik, T. J., Ukimura, O., & Zhu, G. (2011). Treatment of localised renal cell carcinoma. European Urology, 60(4), 662-672.